Akademibokhandeln
Adam Bohr, Kaveh Memarzadeh - Artificial Intelligence in Healthcare, Häftad

Häftad, Engelska, 2027

Artificial Intelligence in Healthcare

Av Adam Bohr, Kaveh Memarzadeh

2299 kr

Kommande

Finns i fler format

Beskrivning
Artificial Intelligence in Healthcare, Second Edition shows where AI is delivering measurable value in medicine today, where it is failing, and what it takes to deploy it responsibly. Substantially rewritten since the first edition of 2020, it reflects the arrival of foundation models, multimodal data, autonomous and agentic systems, and the regulatory frameworks now shaping their use. Twelve chapters by leading practitioners cover AI-driven healthcare transformation and the gap between hype and real-world impact; next-generation drug discovery and molecular design; intelligent drug delivery and pharmaceutical innovation; oncology, from diagnostics to precision treatment pathways; medical imaging; medical devices; surgical intelligence; next-generation digital care; security, privacy and information sharing; insurance and personalised risk; and the ethical and legal questions that decide whether the machine can be trusted. Throughout, the emphasis is on evidence rather than promise: what problem each application solves, where it works in practice, where it fails, and what it means clinically and economically. Written for clinicians, healthcare leaders, industry and policymakers as well as researchers in computer science, data science, bioinformatics and biomedical engineering, it is a practical decision-making tool rather than a technical manual or an academic survey.

  • Maps real world performance against the hype across drug discovery, oncology, imaging, surgery, medical devices, digital care and insurance
  • Covers foundation models, agentic systems and ambient intelligence
  • Explains regulatory pathways (FDA, EMA, MHRA, EU AI Act) for AI in medical devices and clinical use, updated for 2025 to 2026
  • Addresses security, privacy, ethics, law and liability so AI can be deployed responsibly
Produktinformation
  • Utgivningsdatum: 2027-06-01
  • Mått: 152 x 229 x undefined mm
  • Format: Häftad
  • Språk: Engelska
  • Antal sidor: 400
  • Upplaga: 2
  • Förlag: Elsevier Science
  • ISBN: 9780443485831
Utforska kategorier
Mer information

Adam Bohr, PhD, holds a doctorate in Biomedical Engineering from University College London and brings over a decade of experience across pharmaceutical sciences, academia, and industry. He currently leads digital transformation initiatives in drug discovery and development at Novo, a global healthcare and pharmaceutical company. He specializes in healthcare AI applications and in addition to his industry role he is the founder and technical lead of Sonohaler, an AI-driven respiratory health company, as well as a co-founder of Zerion Pharma. He co-edited the first edition of Artificial Intelligence in Healthcare and has authored more than 50 peer-reviewed articles. He also lectures in several university courses on AI applications in drug discovery and development at the University of Copenhagen. Kaveh Memarzadeh, PhD, is Director, UK and Ireland, at ChemoMetec, a life science instrumentation company specialising in automated cell counting and analysis. His career combines scientific research with team leadership and the commercialisation of life science technologies. He previously oversaw research management and communications at Orthopaedic Research UK, where he established a funding initiative to help startups develop their ideas and progress towards commercialisation. He holds research affiliations with University College London and Queen Mary University of London, and a PhD in nanotechnology, biomaterials and microbiology. He has published widely in peer-reviewed journals, including work on antimicrobial biomaterials and implant technologies. He co-edited the first edition of Artificial Intelligence in Healthcare (2020).

Butikslager

Ej i lager i butik.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.